
Global Hemp Group Inc. — Investor Relations & Filings
Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2025-10-09 | English | |
| News release - English.pdf | 2025-04-08 | English | |
| News release - English.pdf | 2025-03-27 | English | |
| News release - English.pdf | 2025-03-18 | English | |
| News release - English.pdf | 2025-03-13 | English | |
| News release - English.pdf | 2025-02-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
13 filings
| |||||
| 32343196 | News release - English.pdf | 2025-10-09 | English | ||
| 13784058 | News release - English.pdf | 2025-04-08 | English | ||
| 13780675 | News release - English.pdf | 2025-03-27 | English | ||
| 13777976 | News release - English.pdf | 2025-03-18 | English | ||
| 13777388 | News release - English.pdf | 2025-03-13 | English | ||
| 13771229 | News release - English.pdf | 2025-02-27 | English | ||
| 31698288 | News release - English.pdf | 2025-02-13 | English | ||
| 31642029 | News release - English.pdf | 2025-01-30 | English | ||
| 13766220 | Report of exempt distribution (45-106F1).pdf | 2025-01-28 | English | ||
| 13765230 | Material change report - English.pdf | 2025-01-20 | English | ||
| 13765424 | News release - English.pdf | 2025-01-18 | English | ||
| 13764767 | News release - English.pdf | 2025-01-11 | English | ||
| 13764325 | News release - English.pdf | 2025-01-07 | English | ||
|
2024
2 filings
| |||||
| 13762019 | News release - English.pdf | 2024-12-12 | English | ||
| 13762017 | News release - English.pdf | 2024-12-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
|
C4 Therapeutics, Inc.
Clinical-stage biopharma developing targeted protein degrad…
|
CCCC | US | Manufacturing |
|
Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel ant…
|
CVKD | US | Manufacturing |
|
CalciMedica, Inc.
Develops CRAC channel inhibitors for acute inflammatory and…
|
CALC | US | Manufacturing |
|
Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses f…
|
CLDI | US | Manufacturing |
|
Calliditas Therapeutics
Biopharma company developing and commercializing treatments…
|
CALTX | SE | Manufacturing |
|
Callitas Health Inc.
Clinical-stage biomedical company developing pharma and OTC…
|
MPHMF | CA | Manufacturing |
|
CALTH. Inc
Develops in vitro diagnostic tools for point-of-care and se…
|
402420 | KR | Manufacturing |
|
Cambrex
A CDMO providing drug substance, drug product, and analytic…
|
CBM | US | Manufacturing |
|
CAMBRIDGE NUTRITIONAL SCIENCES PLC
Develops and manufactures diagnostic tests for food sensiti…
|
CNSL | GB | Manufacturing |
Global Hemp Group Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46553/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46553 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46553 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46553 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46553}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Global Hemp Group Inc. (id: 46553)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.